from django.core.management import call_command
from django.core.management.base import CommandError
from django.test import TestCase
import gzip
import mock
import responses

from seqr.management.commands.reload_clinvar_all_variants import WEEKLY_XML_RELEASE

WEEKLY_XML_RELEASE_DATA = '''<?xml version="1.0" encoding="UTF-8" standalone="yes"?><ClinVarVariationRelease xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://ftp.ncbi.nlm.nih.gov/pub/clinvar/xsd_public/ClinVar_VCV_2.4.xsd" ReleaseDate="2025-06-30"><VariationArchive VariationID="5603" VariationName="NM_007194.4(CHEK2):c.1283C>T (p.Ser428Phe)" VariationType="single nucleotide variant" Accession="VCV000005603" Version="104" RecordType="classified" NumberOfSubmissions="38" NumberOfSubmitters="36" DateLastUpdated="2025-06-29" DateCreated="2016-03-20" MostRecentSubmission="2025-06-29"><RecordStatus>current</RecordStatus><Species>Homo sapiens</Species><ClassifiedRecord><SimpleAllele AlleleID="20642" VariationID="5603"><GeneList><Gene Symbol="CHEK2" FullName="checkpoint kinase 2" GeneID="11200" HGNC_ID="HGNC:16627" Source="submitted" RelationshipType="within single gene"><Location><CytogeneticLocation>22q12.1</CytogeneticLocation><SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="28687743" stop="28741834" display_start="28687743" display_stop="28741834" Strand="-"/><SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="29083730" stop="29137821" display_start="29083730" display_stop="29137821" Strand="-"/></Location><OMIM>604373</OMIM><Haploinsufficiency last_evaluated="2020-01-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CHEK2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency><Triplosensitivity last_evaluated="2020-01-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CHEK2">No evidence available</Triplosensitivity></Gene></GeneList><Name>NM_007194.4(CHEK2):c.1283C>T (p.Ser428Phe)</Name><CanonicalSPDI>NC_000022.11:28695218:G:A</CanonicalSPDI><VariantType>single nucleotide variant</VariantType><Location><CytogeneticLocation>22q12.1</CytogeneticLocation><SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="28695219" stop="28695219" display_start="28695219" display_stop="28695219" variantLength="1" positionVCF="28695219" referenceAlleleVCF="G" alternateAlleleVCF="A"/><SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="29091207" stop="29091207" display_start="29091207" display_stop="29091207" variantLength="1" positionVCF="29091207" referenceAlleleVCF="G" alternateAlleleVCF="A"/></Location><OtherNameList><Name>p.S428F:TCT>TTT</Name></OtherNameList><ProteinChange>S428F</ProteinChange><ProteinChange>S399F</ProteinChange><ProteinChange>S207F</ProteinChange><ProteinChange>S361F</ProteinChange><ProteinChange>S471F</ProteinChange><HGVSlist><HGVS Type="protein"><ProteinExpression sequenceAccessionVersion="O96017" sequenceAccession="O96017" change="p.Ser428Phe"><Expression>O96017:p.Ser428Phe</Expression></ProteinExpression></HGVS><HGVS Assembly="GRCh37" Type="genomic, top-level"><NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.29091207G>A" Assembly="GRCh37"><Expression>NC_000022.10:g.29091207G>A</Expression></NucleotideExpression></HGVS><HGVS Assembly="GRCh38" Type="genomic, top-level"><NucleotideExpression sequenceAccessionVersion="NC_000022.11" sequenceAccession="NC_000022" sequenceVersion="11" change="g.28695219G>A" Assembly="GRCh38"><Expression>NC_000022.11:g.28695219G>A</Expression></NucleotideExpression></HGVS><HGVS Type="genomic"><NucleotideExpression sequenceAccessionVersion="NG_008150.2" sequenceAccession="NG_008150" sequenceVersion="2" change="g.51648C>T"><Expression>NG_008150.2:g.51648C>T</Expression></NucleotideExpression></HGVS><HGVS Type="coding"><NucleotideExpression sequenceAccessionVersion="NM_001005735.2" sequenceAccession="NM_001005735" sequenceVersion="2" change="c.1412C>T"><Expression>NM_001005735.2:c.1412C>T</Expression></NucleotideExpression><ProteinExpression sequenceAccessionVersion="NP_001005735.1" sequenceAccession="NP_001005735" sequenceVersion="1" change="p.Ser471Phe"><Expression>NP_001005735.1:p.Ser471Phe</Expression></ProteinExpression><MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO"/></HGVS><HGVS Type="coding"><NucleotideExpression sequenceAccessionVersion="NM_001257387.2" sequenceAccession="NM_001257387" sequenceVersion="2" change="c.620C>T"><Expression>NM_001257387.2:c.620C>T</Expression></NucleotideExpression><ProteinExpression sequenceAccessionVersion="NP_001244316.1" sequenceAccession="NP_001244316" sequenceVersion="1" change="p.Ser207Phe"><Expression>NP_001244316.1:p.Ser207Phe</Expression></ProteinExpression><MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO"/></HGVS><HGVS Type="coding"><NucleotideExpression sequenceAccessionVersion="NM_001349956.2" sequenceAccession="NM_001349956" sequenceVersion="2" change="c.1082C>T"><Expression>NM_001349956.2:c.1082C>T</Expression></NucleotideExpression><ProteinExpression sequenceAccessionVersion="NP_001336885.1" sequenceAccession="NP_001336885" sequenceVersion="1" change="p.Ser361Phe"><Expression>NP_001336885.1:p.Ser361Phe</Expression></ProteinExpression><MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO"/></HGVS><HGVS Type="coding"><NucleotideExpression sequenceAccessionVersion="NM_007194.4" sequenceAccession="NM_007194" sequenceVersion="4" change="c.1283C>T" MANESelect="true"><Expression>NM_007194.4:c.1283C>T</Expression></NucleotideExpression><ProteinExpression sequenceAccessionVersion="NP_009125.1" sequenceAccession="NP_009125" sequenceVersion="1" change="p.Ser428Phe"><Expression>NP_009125.1:p.Ser428Phe</Expression></ProteinExpression><MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO"/></HGVS><HGVS Type="coding"><NucleotideExpression sequenceAccessionVersion="NM_145862.2" sequenceAccession="NM_145862" sequenceVersion="2" change="c.1196C>T"><Expression>NM_145862.2:c.1196C>T</Expression></NucleotideExpression><ProteinExpression sequenceAccessionVersion="NP_665861.1" sequenceAccession="NP_665861" sequenceVersion="1" change="p.Ser399Phe"><Expression>NP_665861.1:p.Ser399Phe</Expression></ProteinExpression><MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO"/></HGVS><HGVS Type="genomic"><NucleotideExpression sequenceAccessionVersion="LRG_302" sequenceAccession="LRG_302"><Expression>LRG_302:g.51648C>T</Expression></NucleotideExpression></HGVS><HGVS Type="coding"><NucleotideExpression sequenceAccessionVersion="LRG_302t1" sequenceAccession="LRG_302t1"><Expression>LRG_302t1:c.1283C>T</Expression></NucleotideExpression><ProteinExpression sequenceAccessionVersion="LRG_302p1" sequenceAccession="LRG_302p1" change="p.Ser428Phe"><Expression>LRG_302p1:p.Ser428Phe</Expression></ProteinExpression></HGVS></HGVSlist><XRefList><XRef ID="CA250528" DB="ClinGen"/><XRef ID="GTR000558872" DB="Genetic Testing Registry (GTR)"/><XRef ID="O96017#VAR_022463" DB="UniProtKB"/><XRef Type="Allelic variant" ID="604373.0014" DB="OMIM"/><XRef Type="rs" ID="137853011" DB="dbSNP"/></XRefList><AlleleFrequencyList><AlleleFrequency Value="0.00031" Source="Exome Aggregation Consortium (ExAC)"/><AlleleFrequency Value="0.00049" Source="The Genome Aggregation Database (gnomAD), exomes"/><AlleleFrequency Value="0.00026" Source="The Genome Aggregation Database (gnomAD), exomes"/><AlleleFrequency Value="0.00026" Source="The Genome Aggregation Database (gnomAD)"/><AlleleFrequency Value="0.00025" Source="The Genome Aggregation Database (gnomAD)"/><AlleleFrequency Value="0.00028" Source="Trans-Omics for Precision Medicine (TOPMed)"/></AlleleFrequencyList></SimpleAllele><Classifications><GermlineClassification DateLastEvaluated="2025-04-01" NumberOfSubmissions="38" NumberOfSubmitters="36" DateCreated="2016-03-20" MostRecentSubmission="2025-06-29"><ReviewStatus>criteria provided, conflicting classifications</ReviewStatus><Description>Conflicting classifications of pathogenicity</Description><Explanation DataSource="ClinVar" Type="public">Pathogenic(18); Likely pathogenic(9); Pathogenic, low penetrance(1); Established risk allele(1); Likely risk allele(1); Uncertain significance(1)</Explanation><Citation Type="general"><ID Source="PubMed">15649950</ID></Citation><Citation Type="general"><ID Source="PubMed">16551709</ID></Citation><Citation Type="general"><ID Source="PubMed">16914568</ID></Citation><Citation Type="general"><ID Source="PubMed">18085035</ID></Citation><Citation Type="general"><ID Source="PubMed">18571837</ID></Citation><Citation Type="general"><ID Source="PubMed">18706089</ID></Citation><Citation Type="general"><ID Source="PubMed">22419737</ID></Citation><Citation Type="general"><ID Source="PubMed">24506336</ID></Citation><Citation Type="general"><ID Source="PubMed">25503501</ID></Citation><Citation Type="general"><ID Source="PubMed">26270727</ID></Citation><Citation Type="general"><ID Source="PubMed">26681312</ID></Citation><Citation Type="general"><ID Source="PubMed">26845104</ID></Citation><Citation Type="general"><ID Source="PubMed">27153395</ID></Citation><Citation Type="general"><ID Source="PubMed">27433846</ID></Citation><Citation Type="general"><ID Source="PubMed">27621404</ID></Citation><Citation Type="general"><ID Source="PubMed">27751358</ID></Citation><Citation Type="general"><ID Source="PubMed">27798748</ID></Citation><Citation Type="general"><ID Source="PubMed">27806230</ID></Citation><Citation Type="general"><ID Source="PubMed">28135139</ID></Citation><Citation Type="general"><ID Source="PubMed">28135145</ID></Citation><Citation Type="general"><ID Source="PubMed">28495237</ID></Citation><Citation Type="general"><ID Source="PubMed">28727877</ID></Citation><Citation Type="general"><ID Source="PubMed">28944238</ID></Citation><Citation Type="general"><ID Source="PubMed">28981386</ID></Citation><Citation Type="general"><ID Source="PubMed">29785153</ID></Citation><Citation Type="general"><ID Source="PubMed">29961768</ID></Citation><Citation Type="general"><ID Source="PubMed">30152102</ID></Citation><Citation Type="general"><ID Source="PubMed">30676620</ID></Citation><Citation Type="general"><ID Source="PubMed">31159747</ID></Citation><Citation Type="general"><ID Source="PubMed">31360903</ID></Citation><Citation Type="general"><ID Source="PubMed">31948886</ID></Citation><Citation Type="general"><ID Source="PubMed">31980526</ID></Citation><Citation Type="general"><ID Source="PubMed">33471974</ID></Citation><Citation Type="general"><ID Source="PubMed">33471991</ID></Citation><Citation Type="general"><ID Source="PubMed">34622392</ID></Citation><Citation Type="general"><ID Source="PubMed">35264596</ID></Citation><Citation Type="general"><ID Source="PubMed">36136322</ID></Citation><Citation Type="general"><ID Source="PubMed">37449874</ID></Citation><Citation Type="general"><ID Source="PubMed">37490054</ID></Citation><Comment DataSource="ClinVar" Type="public">Pathogenic(18); Likely pathogenic(9); Pathogenic, low penetrance(1); Established risk allele(1); Likely risk allele(1); Uncertain significance(1)</Comment><DescriptionHistory Dated="2024-08-17"><Description>Pathogenic/Likely pathogenic/Pathogenic, low penetrance/Established risk allele</Description></DescriptionHistory><DescriptionHistory Dated="2024-02-03"><Description>Conflicting classifications of pathogenicity</Description></DescriptionHistory><DescriptionHistory Dated="2019-08-13"><Description>Conflicting classifications of pathogenicity, risk factor</Description></DescriptionHistory><DescriptionHistory Dated="2016-12-05"><Description>Pathogenic, risk factor</Description></DescriptionHistory><ConditionList><TraitSet ID="87068" Type="Disease" ContributesToAggregateClassification="false"><Trait ID="68739" Type="Disease"><Name><ElementValue Type="Preferred">TUMOR PREDISPOSITION SYNDROME 4, BREAST</ElementValue><XRef Type="Allelic variant" ID="604373.0014" DB="OMIM"/><XRef Type="Allelic variant" ID="604373.0015" DB="OMIM"/></Name></Trait></TraitSet><TraitSet ID="66954" Type="Disease" ContributesToAggregateClassification="true"><Trait ID="56161" Type="Disease"><Name><ElementValue Type="Preferred">CHEK2-related cancer risk</ElementValue></Name></Trait></TraitSet><TraitSet ID="7920" Type="Disease" ContributesToAggregateClassification="true"><Trait ID="16761" Type="Disease"><Name><ElementValue Type="Preferred">Hereditary breast ovarian cancer syndrome</ElementValue><XRef ID="MONDO:0003582" DB="MONDO"/></Name><Name><ElementValue Type="Alternate">Breast and ovarian cancer</ElementValue></Name><Name><ElementValue Type="Alternate">Hereditary breast and ovarian cancer syndrome (HBOC)</ElementValue></Name><Name><ElementValue Type="Alternate">Hereditary breast and ovarian cancer syndrome</ElementValue><XRef ID="D061325" DB="MeSH"/></Name><Name><ElementValue Type="Alternate">Hereditary breast and ovarian cancer</ElementValue><XRef ID="UWMG_4506306" DB="CSER _CC_NCGL, University of Washington"/></Name><Name><ElementValue Type="Alternate">Hereditary breast and/or ovarian cancer syndrome</ElementValue><XRef ID="145" DB="Orphanet"/></Name><Symbol><ElementValue Type="Alternate">HBOC</ElementValue></Symbol><AttributeSet><Attribute Type="public definition">BRCA1- and BRCA2-associated hereditary breast and ovarian cancer (HBOC) is characterized by an increased risk for female and male breast cancer, ovarian cancer (including fallopian tube and primary peritoneal cancers), and to a lesser extent other cancers such as prostate cancer, pancreatic cancer, and melanoma primarily in individuals with a BRCA2 pathogenic variant. The risk of developing an associated cancer varies depending on whether HBOC is caused by a BRCA1 or BRCA2 pathogenic variant.</Attribute><XRef ID="NBK1247" DB="GeneReviews"/></AttributeSet><AttributeSet><Attribute Type="GARD id" integerValue="15010"/><XRef ID="15010" DB="Office of Rare Diseases"/></AttributeSet><AttributeSet><Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute><XRef ID="GTR000325409" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000502103" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000509978" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000514601" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000558867" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000592450" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000604264" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000509982" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000509985" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000521499" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000528915" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000552245" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000552302" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000558503" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000021468" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000325401" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000330054" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000501981" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000509984" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000521908" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000528916" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000562228" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000595973" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000021517" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000509980" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000509983" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000521909" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000522278" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000522559" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000527942" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000530120" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000558910" DB="Genetic Testing Registry (GTR)"/></AttributeSet><Citation Type="review" Abbrev="GeneReviews"><ID Source="PubMed">20301425</ID><ID Source="BookShelf">NBK1247</ID></Citation><Citation Type="general" Abbrev="ACS, 2007"><ID Source="PubMed">17392385</ID></Citation><Citation Type="general" Abbrev="ASCO, 2010"><ID Source="PubMed">20065170</ID></Citation><Citation Type="general" Abbrev="ASCO, 2003"><ID Source="PubMed">12692171</ID></Citation><Citation Type="general" Abbrev="NSGC, 2004"><ID Source="PubMed">15604628</ID></Citation><Citation Type="review" Abbrev="Stratton and Rahman, 2008"><ID Source="PubMed">18163131</ID></Citation><Citation Type="general" Abbrev="NSGC, 2007"><ID Source="PubMed">17508274</ID></Citation><Citation Type="general" Abbrev="ACOG, 2009"><ID Source="PubMed">19305347</ID></Citation><Citation Type="general" Abbrev="ACMG, 2013"><ID Source="PubMed">23788249</ID></Citation><Citation Type="Suggested Reading" Abbrev="Phillips et al., 2013"><ID Source="PubMed">23918944</ID></Citation><Citation Type="Suggested Reading" Abbrev="Domchek et al., 2010"><ID Source="pmc">2948529</ID></Citation><Citation Type="general" Abbrev="ASCO, 2014"><ID Source="PubMed">24493721</ID></Citation><Citation Type="general" Abbrev="USPSTF, 2014 [Archived]"><ID Source="PubMed">24366376</ID></Citation><Citation Type="general" Abbrev="NSGC, 2013"><ID Source="PubMed">23188549</ID></Citation><Citation Type="general" Abbrev="USPSTF, 2014"><ID Source="PubMed">24366402</ID></Citation><Citation Type="Suggested Reading" Abbrev="USPSTF, 2013"><ID Source="PubMed">24432435</ID></Citation><Citation Type="general" Abbrev="ACMG, 2015"><ID Source="PubMed">25356965</ID></Citation><Citation Type="general" Abbrev="ACMG, 2016"><ID Source="PubMed">27854360</ID><ID Source="DOI">10.1038/gim.2016.190</ID></Citation><Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling"><ID Source="PubMed">26389258</ID></Citation><Citation Type="general" Abbrev="NSGC, 2021"><ID Source="PubMed">33410258</ID></Citation><Citation Type="general" Abbrev="ASCO, 2015"><ID Source="PubMed">26324357</ID></Citation><Citation Type="practice guideline" Abbrev="NCCN, 2022"><CitationText>NCCN Clinical Practice Guidelines in Oncology, Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic version 2.2022</CitationText></Citation><Citation Type="general" Abbrev="USPSTF, 2019"><ID Source="PubMed">31429903</ID></Citation><Citation Type="Suggested Reading" Abbrev="USPSTF, 2019"><ID Source="PubMed">31479213</ID><ID Source="BookShelf">NBK545867</ID></Citation><Citation Type="practice guideline" Abbrev="ACMG ACT, 2019"><CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, BRCA1 and BRCA2 Pathogenic Variants (Hereditary Breast and Ovarian Cancer), 2019</CitationText></Citation><Citation Type="practice guideline" Abbrev="NICE, 2023"><URL>https://www.nice.org.uk/guidance/cg164</URL><CitationText>UK NICE Clinical Guideline CG164, Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer, 2023</CitationText></Citation><Citation Type="practice guideline" Abbrev="NICE, 2023"><URL>https://www.nice.org.uk/guidance/cg122</URL><CitationText>UK NICE Clinical guideline (CG122), Ovarian cancer: recognition and initial management, 2023</CitationText></Citation><Citation Type="practice guideline" Abbrev="EMQN, 2024"><URL>https://www.nature.com/articles/s41431-023-01507-5</URL><CitationText>EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer</CitationText></Citation><Citation Type="practice guideline" Abbrev="UK NICE, 2024"><URL>https://www.nice.org.uk/guidance/ng241</URL><CitationText>UK NICE Guideline NG241, Ovarian cancer: identifying and managing familial and genetic risk, 2024</CitationText></Citation><XRef ID="145" DB="Orphanet"/><XRef ID="C0677776" DB="MedGen"/><XRef ID="D061325" DB="MeSH"/><XRef ID="MONDO:0003582" DB="MONDO"/></Trait></TraitSet><TraitSet ID="12285" Type="Disease" ContributesToAggregateClassification="true"><Trait ID="18285" Type="Disease"><Name><ElementValue Type="Alternate">Breast Neoplasms</ElementValue></Name><Name><ElementValue Type="Preferred">Breast neoplasm</ElementValue><XRef ID="MONDO:0021100" DB="MONDO"/></Name><Name><ElementValue Type="Alternate">Neoplasm of the breast</ElementValue><XRef ID="HP:0100013" DB="Human Phenotype Ontology"/></Name><Name><ElementValue Type="Alternate">Neoplasm of breast</ElementValue><XRef ID="126926005" DB="SNOMED CT"/></Name><Name><ElementValue Type="Alternate">Breast tumor</ElementValue><XRef ID="HP:0100013" DB="Human Phenotype Ontology"/><XRef ID="126926005" DB="SNOMED CT"/></Name><AttributeSet><Attribute Type="disease mechanism" integerValue="274">gain of function</Attribute><XRef ID="GTR000500637" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000502103" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000527942" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000527980" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000529064" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000592350" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000552245" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000552302" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000552440" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000552479" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000561539" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000569910" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000210160" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000501981" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000509982" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000509984" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000514885" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000509980" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000509983" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000530120" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000569904" DB="Genetic Testing Registry (GTR)"/></AttributeSet><Citation Type="general" Abbrev="EGAPP, 2009"><ID Source="pmc">2743614</ID></Citation><Citation Type="practice guideline" Abbrev="NICE, 2013"><URL>https://www.nice.org.uk/guidance/dg10</URL><CitationText>DG10 Gene expression profiling and expanded immunohistochemistry tests for guiding adjuvant chemotherapy decisions in early breast cancer management: MammaPrint, Oncotype DX, IHC4 and Mammostrat: information for the public</CitationText></Citation><Citation Type="general" Abbrev="ASCO, 2007"><ID Source="PubMed">17954709</ID></Citation><Citation Type="general" Abbrev="St. Gallen, 2013"><ID Source="PubMed">23917950</ID></Citation><Citation Type="general" Abbrev="ESMO, 2013"><ID Source="PubMed">23970019</ID></Citation><Citation Type="general" Abbrev="NACB, 2008"><ID Source="PubMed">19042984</ID></Citation><Citation Type="practice guideline" Abbrev="AHRQ, 2013"><URL>https://www.cms.gov/Medicare/Coverage/DeterminationProcess/downloads/id90TA.pdf</URL><CitationText>Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin (ARCHIVED)</CitationText></Citation><Citation Type="general" Abbrev="ASCO/CAP, 2014"><ID Source="pmc">4086638</ID></Citation><Citation Type="Translational/Evidence-based" Abbrev="NCCN, 2011"><ID Source="PubMed">22138009</ID></Citation><Citation Type="general" Abbrev="NSGC, 2013"><ID Source="PubMed">23188549</ID></Citation><Citation Type="general" Abbrev="ASCO, 2014"><ID Source="PubMed">24799465</ID></Citation><Citation Type="general" Abbrev="ASCO, 2014"><ID Source="PubMed">24799487</ID></Citation><Citation Type="general" Abbrev="NCCBP, 2015"><ID Source="PubMed">25488926</ID></Citation><Citation Type="general" Abbrev="ASCO, 2013"><ID Source="PubMed">23835710</ID></Citation><Citation Type="general" Abbrev="USPSTF, 2013"><ID Source="PubMed">24061412</ID></Citation><Citation Type="practice guideline" Abbrev="NICE, 2018"><URL>http://www.nice.org.uk/guidance/dg34</URL><CitationText>Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer, NICE, 2018</CitationText></Citation><Citation Type="practice guideline" Abbrev="NCCN, 2022"><CitationText>Breast Cancer Screening and Diagnosis, NCCN, Version 1.2022</CitationText></Citation><Citation Type="practice guideline" Abbrev="NCCN, 2023"><CitationText>Breast Cancer, NCCN Guidelines Version 4.2022</CitationText></Citation><Citation Type="general" Abbrev="NSGC, 2021"><ID Source="PubMed">33410258</ID></Citation><Citation Type="general" Abbrev="ASCO, 2018"><ID Source="PubMed">29939838</ID></Citation><Citation Type="general" Abbrev="ASCO, 2018"><ID Source="PubMed">29939840</ID></Citation><Citation Type="general" Abbrev="USPSTF, 2019"><ID Source="PubMed">31479144</ID></Citation><Citation Type="practice guideline" Abbrev="NICE, 2018"><URL>https://www.nice.org.uk/guidance/dg34</URL><CitationText>Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer (DG34)</CitationText></Citation><Citation Type="general" Abbrev="St. Gallen, 2021"><ID Source="PubMed">34242744</ID></Citation><Citation Type="practice guideline" Abbrev="NICE, 2025"><URL>https://www.nice.org.uk/guidance/ng101</URL><CitationText>UK NICE Guideline NG101, Early and locally advanced breast cancer: diagnosis and management, 2025</CitationText></Citation><XRef ID="C1458155" DB="MedGen"/><XRef ID="D001943" DB="MeSH"/><XRef ID="MONDO:0021100" DB="MONDO"/><XRef Type="primary" ID="HP:0100013" DB="Human Phenotype Ontology"/><XRef Type="secondary" ID="HP:0010623" DB="Human Phenotype Ontology"/></Trait></TraitSet><TraitSet ID="25616" Type="Finding" ContributesToAggregateClassification="false"><Trait ID="34847" Type="Finding"><Name><ElementValue Type="Alternate">Cancer breast</ElementValue></Name><Name><ElementValue Type="Preferred">Malignant tumor of breast</ElementValue><XRef ID="254837009" DB="SNOMED CT"/></Name><Name><ElementValue Type="Alternate">Malignant breast neoplasm</ElementValue><XRef ID="C9335" DB="NCI"/></Name><AttributeSet><Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute><XRef ID="GTR000604264" DB="Genetic Testing Registry (GTR)"/></AttributeSet><Citation Type="general" Abbrev="ASCO, 2010"><ID Source="pmc">2936467</ID></Citation><Citation Type="Suggested Reading" Abbrev="NCI PDQ, Breast and Gynecologic Cancers"><ID Source="PubMed">26389210</ID></Citation><Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling"><ID Source="PubMed">26389258</ID></Citation><Citation Type="practice guideline" Abbrev="NCCN, 2023"><CitationText>Breast Cancer, NCCN Guidelines Version 4.2022</CitationText></Citation><Citation Type="general" Abbrev="ASCO, 2018"><ID Source="PubMed">29939840</ID></Citation><Citation Type="general" Abbrev="USPSTF, 2019"><ID Source="PubMed">31479144</ID></Citation><Citation Type="general" Abbrev="ASCO, 2019"><ID Source="PubMed">30452337</ID></Citation><Citation Type="practice guideline" Abbrev="NICE, 2018"><URL>https://www.nice.org.uk/guidance/dg34</URL><CitationText>Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer (DG34)</CitationText></Citation><Citation Type="practice guideline" Abbrev="NICE, 2023"><URL>https://www.nice.org.uk/guidance/ng12</URL><CitationText>UK NICE Guideline NG12, Suspected cancer: recognition and referral, 2023</CitationText></Citation><Citation Type="practice guideline" Abbrev="NCCN, 2023"><URL>https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf</URL><CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines速) Breast Cancer, 2023</CitationText></Citation><Citation Type="practice guideline" Abbrev="NICE, 2025"><URL>https://www.nice.org.uk/guidance/ng101</URL><CitationText>UK NICE Guideline NG101, Early and locally advanced breast cancer: diagnosis and management, 2025</CitationText></Citation><Citation Type="practice guideline" Abbrev="UK NICE Clinical Guideline, 2025"><URL>https://www.nice.org.uk/guidance/cg81</URL><CitationText>Advanced breast cancer: diagnosis and treatment, CG81, 2025</CitationText></Citation><XRef ID="C0006142" DB="MedGen"/><XRef ID="MONDO:0007254" DB="MONDO"/></Trait></TraitSet><TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true"><Trait ID="17556" Type="Disease"><Name><ElementValue Type="Preferred">not provided</ElementValue><XRef ID="13DG0619" DB="Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre"/></Name><Name><ElementValue Type="Alternate">none provided</ElementValue></Name><AttributeSet><Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute></AttributeSet><XRef ID="C3661900" DB="MedGen"/></Trait></TraitSet><TraitSet ID="100183" Type="Disease" ContributesToAggregateClassification="true"><Trait ID="2688" Type="Disease"><Name><ElementValue Type="Preferred">CHEK2-related cancer predisposition</ElementValue><XRef ID="MONDO:0700271" DB="MONDO"/></Name><Name><ElementValue Type="Alternate">CHEK2-Related Cancer Susceptibility</ElementValue></Name><Name><ElementValue Type="Alternate">TUMOR PREDISPOSITION SYNDROME 4</ElementValue><XRef Type="MIM" ID="609265" DB="OMIM"/><XRef Type="Allelic variant" ID="604373.0004" DB="OMIM"/><XRef Type="Allelic variant" ID="604373.0003" DB="OMIM"/></Name><Name><ElementValue Type="Alternate">CANCER PREDISPOSITION SYNDROME, CHEK2-RELATED</ElementValue><XRef Type="MIM" ID="609265" DB="OMIM"/></Name><Symbol><ElementValue Type="Alternate">LFS2</ElementValue><XRef Type="MIM" ID="609265" DB="OMIM"/></Symbol><Symbol><ElementValue Type="Preferred">TPDS4</ElementValue><XRef Type="MIM" ID="609265" DB="OMIM"/></Symbol><AttributeSet><Attribute Type="public definition">CHEK2-related cancer predisposition is predominantly characterized by an increased risk of female breast cancer. To a lesser extent there is an association with increased risk of prostate cancer. Associations for other cancers are less well established or conflicting. Cancer risks in those with CHEK2-related cancer predisposition can vary considerably depending on modifying factors such as family history.</Attribute><XRef ID="NBK615090" DB="GeneReviews"/></AttributeSet><Citation Type="Suggested Reading" Abbrev="NCI PDQ, Breast and Gynecologic Cancers"><ID Source="PubMed">26389210</ID></Citation><Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling"><ID Source="PubMed">26389258</ID></Citation><Citation Type="review" Abbrev="GeneReviews"><ID Source="PubMed">40440438</ID><ID Source="BookShelf">NBK615090</ID></Citation><XRef ID="524" DB="Orphanet"/><XRef ID="C5882668" DB="MedGen"/><XRef ID="MONDO:0700271" DB="MONDO"/><XRef Type="MIM" ID="609265" DB="OMIM"/></Trait><Trait ID="3682" Type="Disease"><Name><ElementValue Type="Alternate">Osteosarcoma, somatic</ElementValue></Name><Name><ElementValue Type="Preferred">Bone osteosarcoma</ElementValue><XRef ID="MONDO:0002629" DB="MONDO"/></Name><Symbol><ElementValue Type="Alternate">OSRC</ElementValue><XRef Type="MIM" ID="259500" DB="OMIM"/></Symbol><AttributeSet><Attribute Type="GARD id" integerValue="7284"/><XRef ID="7284" DB="Office of Rare Diseases"/></AttributeSet><Citation Type="practice guideline" Abbrev="NCCN, 2024"><URL>https://www.nccn.org/professionals/physician_gls/pdf/bone.pdf</URL><CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines速) Bone Cancer, 2024</CitationText></Citation><XRef ID="668" DB="Orphanet"/><XRef ID="C0585442" DB="MedGen"/><XRef ID="MONDO:0002629" DB="MONDO"/><XRef Type="MIM" ID="259500" DB="OMIM"/></Trait><Trait ID="7312" Type="Disease"><Name><ElementValue Type="Alternate">Hereditary Prostate Cancer</ElementValue></Name><Name><ElementValue Type="Preferred">Familial prostate cancer</ElementValue><XRef ID="715412008" DB="SNOMED CT"/></Name><Citation Type="general" Abbrev="NSGC, 2004"><ID Source="PubMed">15604628</ID></Citation><Citation Type="Suggested Reading" Abbrev="NCI PDQ, Prostate cancer genetics"><ID Source="PubMed">26389227</ID></Citation><Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling"><ID Source="PubMed">26389258</ID></Citation><Citation Type="practice guideline" Abbrev="NCCN, 2024"><URL>https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf</URL><CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines速), Prostate Cancer, 2024</CitationText></Citation><Citation Type="general" Abbrev="ASCO, 2019"><ID Source="PubMed">31829902</ID></Citation><Citation Type="general" Abbrev="HKUA/HKSU-O, 2022"><ID Source="PubMed">35924163</ID><ID Source="pmc">9339641</ID></Citation><Citation Type="practice guideline" Abbrev="NICE, 2021"><URL>https://www.nice.org.uk/guidance/ng131</URL><CitationText>UK NICE Guideline NG131, Prostate cancer: diagnosis and management, 2021</CitationText></Citation><XRef ID="1331" DB="Orphanet"/><XRef ID="C2931456" DB="MedGen"/><XRef ID="MONDO:0700275" DB="MONDO"/><XRef Type="MIM" ID="176807" DB="OMIM"/></Trait></TraitSet><TraitSet ID="98029" Type="Disease" ContributesToAggregateClassification="true"><Trait ID="76465" Type="Disease"><Name><ElementValue Type="Preferred">Inherited breast cancer and ovarian cancer</ElementValue></Name></Trait></TraitSet><TraitSet ID="82556" Type="Disease" ContributesToAggregateClassification="false"><Trait ID="66797" Type="Disease"><Name><ElementValue Type="Preferred">CHEK2-related disorder</ElementValue></Name></Trait></TraitSet><TraitSet ID="774" Type="Disease" ContributesToAggregateClassification="true"><Trait ID="536" Type="Disease"><Name><ElementValue Type="Preferred">Familial cancer of breast</ElementValue><XRef ID="254843006" DB="SNOMED CT"/></Name><Name><ElementValue Type="Alternate">BREAST CANCER, FAMILIAL</ElementValue><XRef Type="MIM" ID="114480" DB="OMIM"/><XRef Type="Allelic variant" ID="179617.0001" DB="OMIM"/><XRef Type="Allelic variant" ID="607585.0020" DB="OMIM"/></Name><Name><ElementValue Type="Alternate">Hereditary breast cancer</ElementValue></Name><Name><ElementValue Type="Alternate">hereditary breast carcinoma</ElementValue></Name><AttributeSet><Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute><XRef ID="GTR000558503" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000561700" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000569423" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000570011" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000562228" DB="Genetic Testing Registry (GTR)"/></AttributeSet><AttributeSet><Attribute Type="keyword">Hereditary cancer syndrome</Attribute></AttributeSet><AttributeSet><Attribute Type="keyword">Neoplasm</Attribute></AttributeSet><AttributeSet><Attribute Type="GARD id" integerValue="17142"/><XRef ID="17142" DB="Office of Rare Diseases"/></AttributeSet><AttributeSet><Attribute Type="public definition">BRCA1- and BRCA2-associated hereditary breast and ovarian cancer (HBOC) is characterized by an increased risk for female and male breast cancer, ovarian cancer (including fallopian tube and primary peritoneal cancers), and to a lesser extent other cancers such as prostate cancer, pancreatic cancer, and melanoma primarily in individuals with a BRCA2 pathogenic variant. The risk of developing an associated cancer varies depending on whether HBOC is caused by a BRCA1 or BRCA2 pathogenic variant.</Attribute><XRef ID="NBK1247" DB="GeneReviews"/></AttributeSet><Citation Type="review" Abbrev="GeneReviews"><ID Source="PubMed">20301425</ID><ID Source="BookShelf">NBK1247</ID></Citation><Citation Type="general" Abbrev="NSGC, 2004"><ID Source="PubMed">15604628</ID></Citation><Citation Type="review" Abbrev="Stratton and Rahman, 2008"><ID Source="PubMed">18163131</ID></Citation><Citation Type="general" Abbrev="NSGC, 2007"><ID Source="PubMed">17508274</ID></Citation><Citation Type="general" Abbrev="USPSTF, 2014 [Archived]"><ID Source="PubMed">24366376</ID></Citation><Citation Type="general" Abbrev="USPSTF, 2014"><ID Source="PubMed">24366402</ID></Citation><Citation Type="Suggested Reading" Abbrev="USPSTF, 2013"><ID Source="PubMed">24432435</ID></Citation><Citation Type="Suggested Reading" Abbrev="NCI PDQ, Breast and Gynecologic Cancers"><ID Source="PubMed">26389210</ID></Citation><Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling"><ID Source="PubMed">26389258</ID></Citation><Citation Type="general" Abbrev="ACMG SF v3.0, 2021"><ID Source="PubMed">34012068</ID><ID Source="DOI">10.1038/s41436-021-01172-3</ID></Citation><Citation Type="practice guideline" Abbrev="NCCN, 2023"><CitationText>Breast Cancer, NCCN Guidelines Version 4.2022</CitationText></Citation><Citation Type="general" Abbrev="ACMG SF v3.1, 2022"><ID Source="PubMed">35802134</ID><ID Source="DOI">10.1016/j.gim.2022.04.006</ID></Citation><Citation Type="practice guideline" Abbrev="NCCN, 2022"><URL>https://www.nccn.org/professionals/physician_gls/pdf/genetics_bop.pdf</URL><CitationText>NCCN Clinical Practice Guidelines in Oncology, Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic version 2.2022</CitationText></Citation><Citation Type="general" Abbrev="St. Gallen, 2021"><ID Source="PubMed">34242744</ID></Citation><Citation Type="general" Abbrev="USPSTF, 2019"><ID Source="PubMed">31429903</ID></Citation><Citation Type="Suggested Reading" Abbrev="USPSTF, 2019"><ID Source="PubMed">31479213</ID><ID Source="BookShelf">NBK545867</ID></Citation><Citation Type="practice guideline" Abbrev="ACMG ACT, 2019"><URL>https://www.acmg.net/PDFLibrary/Hereditary-Breast-Ovarian-Cancer.pdf</URL><CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, BRCA1 and BRCA2 Pathogenic Variants (Hereditary Breast and Ovarian Cancer), 2019</CitationText></Citation><Citation Type="practice guideline" Abbrev="NICE, 2023"><URL>https://www.nice.org.uk/guidance/cg164</URL><CitationText>UK NICE Clinical Guideline CG164, Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer, 2023</CitationText></Citation><Citation Type="practice guideline" Abbrev="NICE, 2025"><URL>https://www.nice.org.uk/guidance/ng101</URL><CitationText>UK NICE Guideline NG101, Early and locally advanced breast cancer: diagnosis and management, 2025</CitationText></Citation><Citation Type="practice guideline" Abbrev="UK NICE Clinical Guideline, 2025"><URL>https://www.nice.org.uk/guidance/cg81</URL><CitationText>Advanced breast cancer: diagnosis and treatment, CG81, 2025</CitationText></Citation><XRef ID="227535" DB="Orphanet"/><XRef ID="C0346153" DB="MedGen"/><XRef ID="MONDO:0016419" DB="MONDO"/><XRef Type="MIM" ID="114480" DB="OMIM"/></Trait></TraitSet><TraitSet ID="216" Type="Disease" ContributesToAggregateClassification="false"><Trait ID="9673" Type="Disease"><Name><ElementValue Type="Preferred">Breast cancer, susceptibility to</ElementValue></Name><AttributeSet><Attribute Type="disease mechanism" integerValue="274">gain of function</Attribute><XRef ID="GTR000325409" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000512816" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000558503" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000592450" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000604264" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000509982" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000509984" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000509985" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000552245" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000021468" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000210160" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000325401" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000509980" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000525134" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000509983" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000570542" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000592961" DB="Genetic Testing Registry (GTR)"/></AttributeSet><Citation Type="general" Abbrev="NSGC, 2013"><ID Source="PubMed">23188549</ID></Citation><Citation Type="general" Abbrev="NSGC, 2021"><ID Source="PubMed">33410258</ID></Citation><Citation Type="practice guideline" Abbrev="NICE, 2023"><URL>https://www.nice.org.uk/guidance/cg164</URL><CitationText>UK NICE Clinical Guideline CG164, Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer, 2023</CitationText></Citation><XRef ID="C3469522" DB="MedGen"/></Trait></TraitSet><TraitSet ID="1568" Type="Disease" ContributesToAggregateClassification="true"><Trait ID="2688" Type="Disease"><Name><ElementValue Type="Preferred">CHEK2-related cancer predisposition</ElementValue><XRef ID="MONDO:0700271" DB="MONDO"/></Name><Name><ElementValue Type="Alternate">CHEK2-Related Cancer Susceptibility</ElementValue></Name><Name><ElementValue Type="Alternate">TUMOR PREDISPOSITION SYNDROME 4</ElementValue><XRef Type="MIM" ID="609265" DB="OMIM"/><XRef Type="Allelic variant" ID="604373.0004" DB="OMIM"/><XRef Type="Allelic variant" ID="604373.0003" DB="OMIM"/></Name><Name><ElementValue Type="Alternate">CANCER PREDISPOSITION SYNDROME, CHEK2-RELATED</ElementValue><XRef Type="MIM" ID="609265" DB="OMIM"/></Name><Symbol><ElementValue Type="Alternate">LFS2</ElementValue><XRef Type="MIM" ID="609265" DB="OMIM"/></Symbol><Symbol><ElementValue Type="Preferred">TPDS4</ElementValue><XRef Type="MIM" ID="609265" DB="OMIM"/></Symbol><AttributeSet><Attribute Type="public definition">CHEK2-related cancer predisposition is predominantly characterized by an increased risk of female breast cancer. To a lesser extent there is an association with increased risk of prostate cancer. Associations for other cancers are less well established or conflicting. Cancer risks in those with CHEK2-related cancer predisposition can vary considerably depending on modifying factors such as family history.</Attribute><XRef ID="NBK615090" DB="GeneReviews"/></AttributeSet><Citation Type="Suggested Reading" Abbrev="NCI PDQ, Breast and Gynecologic Cancers"><ID Source="PubMed">26389210</ID></Citation><Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling"><ID Source="PubMed">26389258</ID></Citation><Citation Type="review" Abbrev="GeneReviews"><ID Source="PubMed">40440438</ID><ID Source="BookShelf">NBK615090</ID></Citation><XRef ID="524" DB="Orphanet"/><XRef ID="C5882668" DB="MedGen"/><XRef ID="MONDO:0700271" DB="MONDO"/><XRef Type="MIM" ID="609265" DB="OMIM"/></Trait></TraitSet><TraitSet ID="1569" Type="Disease" ContributesToAggregateClassification="true"><Trait ID="10179" Type="Disease"><Name><ElementValue Type="Preferred">Breast and colorectal cancer, susceptibility to</ElementValue></Name><Name><ElementValue Type="Alternate">HBCC, susceptibility to</ElementValue></Name><XRef ID="CN068920" DB="MedGen"/></Trait></TraitSet><TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true"><Trait ID="18746" Type="Disease"><Name><ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue><XRef ID="MONDO:0015356" DB="MONDO"/></Name><Name><ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue><XRef ID="D009386" DB="MeSH"/></Name><Name><ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue><XRef ID="699346009" DB="SNOMED CT"/></Name><Name><ElementValue Type="Alternate">Tumor predisposition</ElementValue></Name><Name><ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue></Name><AttributeSet><Attribute Type="keyword">Hereditary cancer syndrome</Attribute></AttributeSet><AttributeSet><Attribute Type="keyword">Neoplasm</Attribute></AttributeSet><AttributeSet><Attribute Type="GARD id" integerValue="19921"/><XRef ID="19921" DB="Office of Rare Diseases"/></AttributeSet><Citation Type="general" Abbrev="IARC, 2008"><ID Source="pmc">3075918</ID></Citation><Citation Type="general" Abbrev="ACMG/NSGC, 2015"><ID Source="PubMed">25394175</ID></Citation><XRef ID="140162" DB="Orphanet"/><XRef ID="C0027672" DB="MedGen"/><XRef ID="D009386" DB="MeSH"/><XRef ID="MONDO:0015356" DB="MONDO"/></Trait></TraitSet><TraitSet ID="20192" Type="Disease" ContributesToAggregateClassification="true"><Trait ID="32337" Type="Disease"><Name><ElementValue Type="Preferred">Breast and/or ovarian cancer</ElementValue><XRef ID="UWMG_7622958" DB="CSER _CC_NCGL, University of Washington"/></Name><XRef ID="CN221562" DB="MedGen"/></Trait></TraitSet><TraitSet ID="13787" Type="Disease" ContributesToAggregateClassification="true"><Trait ID="5807" Type="Disease"><Name><ElementValue Type="Preferred">Prostate cancer</ElementValue><XRef ID="HP:0012125" DB="Human Phenotype Ontology"/><XRef ID="MONDO:0008315" DB="MONDO"/></Name><Name><ElementValue Type="Alternate">Malignant tumor of prostate</ElementValue><XRef ID="399068003" DB="SNOMED CT"/></Name><Citation Type="general" Abbrev="NACB, 2008"><ID Source="PubMed">19042984</ID></Citation><Citation Type="general" Abbrev="EGAPP, 2014"><ID Source="PubMed">24071797</ID></Citation><Citation Type="Translational/Evidence-based" Abbrev="NCCN, 2011"><ID Source="PubMed">22138009</ID></Citation><Citation Type="general" Abbrev="ACMG/NSGC, 2015"><ID Source="PubMed">25394175</ID></Citation><Citation Type="general" Abbrev="AUA, 2018"><ID Source="PubMed">23659877</ID></Citation><Citation Type="Suggested Reading" Abbrev="NCI PDQ, Prostate cancer genetics"><ID Source="PubMed">26389227</ID></Citation><Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling"><ID Source="PubMed">26389258</ID></Citation><Citation Type="practice guideline" Abbrev="NCCN, 2024"><URL>https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf</URL><CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines速), Prostate Cancer, 2024</CitationText></Citation><Citation Type="general" Abbrev="ASCO, 2021"><ID Source="PubMed">33497248</ID></Citation><Citation Type="general" Abbrev="ASCO, 2019"><ID Source="PubMed">31829902</ID></Citation><Citation Type="general" Abbrev="HKUA/HKSU-O, 2022"><ID Source="PubMed">35924163</ID><ID Source="pmc">9339641</ID></Citation><Citation Type="practice guideline" Abbrev="NICE, 2023"><URL>https://www.nice.org.uk/guidance/ng12</URL><CitationText>UK NICE Guideline NG12, Suspected cancer: recognition and referral, 2023</CitationText></Citation><Citation Type="practice guideline" Abbrev="NICE, 2021"><URL>https://www.nice.org.uk/guidance/ng131</URL><CitationText>UK NICE Guideline NG131, Prostate cancer: diagnosis and management, 2021</CitationText></Citation><XRef ID="1331" DB="Orphanet"/><XRef ID="C0376358" DB="MedGen"/><XRef ID="MONDO:0008315" DB="MONDO"/><XRef Type="primary" ID="HP:0012125" DB="Human Phenotype Ontology"/></Trait><Trait ID="2688" Type="Disease"><Name><ElementValue Type="Preferred">CHEK2-related cancer predisposition</ElementValue><XRef ID="MONDO:0700271" DB="MONDO"/></Name><Name><ElementValue Type="Alternate">CHEK2-Related Cancer Susceptibility</ElementValue></Name><Name><ElementValue Type="Alternate">TUMOR PREDISPOSITION SYNDROME 4</ElementValue><XRef Type="MIM" ID="609265" DB="OMIM"/><XRef Type="Allelic variant" ID="604373.0004" DB="OMIM"/><XRef Type="Allelic variant" ID="604373.0003" DB="OMIM"/></Name><Name><ElementValue Type="Alternate">CANCER PREDISPOSITION SYNDROME, CHEK2-RELATED</ElementValue><XRef Type="MIM" ID="609265" DB="OMIM"/></Name><Symbol><ElementValue Type="Alternate">LFS2</ElementValue><XRef Type="MIM" ID="609265" DB="OMIM"/></Symbol><Symbol><ElementValue Type="Preferred">TPDS4</ElementValue><XRef Type="MIM" ID="609265" DB="OMIM"/></Symbol><AttributeSet><Attribute Type="public definition">CHEK2-related cancer predisposition is predominantly characterized by an increased risk of female breast cancer. To a lesser extent there is an association with increased risk of prostate cancer. Associations for other cancers are less well established or conflicting. Cancer risks in those with CHEK2-related cancer predisposition can vary considerably depending on modifying factors such as family history.</Attribute><XRef ID="NBK615090" DB="GeneReviews"/></AttributeSet><Citation Type="Suggested Reading" Abbrev="NCI PDQ, Breast and Gynecologic Cancers"><ID Source="PubMed">26389210</ID></Citation><Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling"><ID Source="PubMed">26389258</ID></Citation><Citation Type="review" Abbrev="GeneReviews"><ID Source="PubMed">40440438</ID><ID Source="BookShelf">NBK615090</ID></Citation><XRef ID="524" DB="Orphanet"/><XRef ID="C5882668" DB="MedGen"/><XRef ID="MONDO:0700271" DB="MONDO"/><XRef Type="MIM" ID="609265" DB="OMIM"/></Trait><Trait ID="536" Type="Disease"><Name><ElementValue Type="Preferred">Familial cancer of breast</ElementValue><XRef ID="254843006" DB="SNOMED CT"/></Name><Name><ElementValue Type="Alternate">BREAST CANCER, FAMILIAL</ElementValue><XRef Type="MIM" ID="114480" DB="OMIM"/><XRef Type="Allelic variant" ID="179617.0001" DB="OMIM"/><XRef Type="Allelic variant" ID="607585.0020" DB="OMIM"/></Name><Name><ElementValue Type="Alternate">Hereditary breast cancer</ElementValue></Name><Name><ElementValue Type="Alternate">hereditary breast carcinoma</ElementValue></Name><AttributeSet><Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute><XRef ID="GTR000558503" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000561700" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000569423" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000570011" DB="Genetic Testing Registry (GTR)"/><XRef ID="GTR000562228" DB="Genetic Testing Registry (GTR)"/></AttributeSet><AttributeSet><Attribute Type="keyword">Hereditary cancer syndrome</Attribute></AttributeSet><AttributeSet><Attribute Type="keyword">Neoplasm</Attribute></AttributeSet><AttributeSet><Attribute Type="GARD id" integerValue="17142"/><XRef ID="17142" DB="Office of Rare Diseases"/></AttributeSet><AttributeSet><Attribute Type="public definition">BRCA1- and BRCA2-associated hereditary breast and ovarian cancer (HBOC) is characterized by an increased risk for female and male breast cancer, ovarian cancer (including fallopian tube and primary peritoneal cancers), and to a lesser extent other cancers such as prostate cancer, pancreatic cancer, and melanoma primarily in individuals with a BRCA2 pathogenic variant. The risk of developing an associated cancer varies depending on whether HBOC is caused by a BRCA1 or BRCA2 pathogenic variant.</Attribute><XRef ID="NBK1247" DB="GeneReviews"/></AttributeSet><Citation Type="review" Abbrev="GeneReviews"><ID Source="PubMed">20301425</ID><ID Source="BookShelf">NBK1247</ID></Citation><Citation Type="general" Abbrev="NSGC, 2004"><ID Source="PubMed">15604628</ID></Citation><Citation Type="review" Abbrev="Stratton and Rahman, 2008"><ID Source="PubMed">18163131</ID></Citation><Citation Type="general" Abbrev="NSGC, 2007"><ID Source="PubMed">17508274</ID></Citation><Citation Type="general" Abbrev="USPSTF, 2014 [Archived]"><ID Source="PubMed">24366376</ID></Citation><Citation Type="general" Abbrev="USPSTF, 2014"><ID Source="PubMed">24366402</ID></Citation><Citation Type="Suggested Reading" Abbrev="USPSTF, 2013"><ID Source="PubMed">24432435</ID></Citation><Citation Type="Suggested Reading" Abbrev="NCI PDQ, Breast and Gynecologic Cancers"><ID Source="PubMed">26389210</ID></Citation><Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling"><ID Source="PubMed">26389258</ID></Citation><Citation Type="general" Abbrev="ACMG SF v3.0, 2021"><ID Source="PubMed">34012068</ID><ID Source="DOI">10.1038/s41436-021-01172-3</ID></Citation><Citation Type="practice guideline" Abbrev="NCCN, 2023"><CitationText>Breast Cancer, NCCN Guidelines Version 4.2022</CitationText></Citation><Citation Type="general" Abbrev="ACMG SF v3.1, 2022"><ID Source="PubMed">35802134</ID><ID Source="DOI">10.1016/j.gim.2022.04.006</ID></Citation><Citation Type="practice guideline" Abbrev="NCCN, 2022"><CitationText>NCCN Clinical Practice Guidelines in Oncology, Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic version 2.2022</CitationText></Citation><Citation Type="general" Abbrev="St. Gallen, 2021"><ID Source="PubMed">34242744</ID></Citation><Citation Type="general" Abbrev="USPSTF, 2019"><ID Source="PubMed">31429903</ID></Citation><Citation Type="Suggested Reading" Abbrev="USPSTF, 2019"><ID Source="PubMed">31479213</ID><ID Source="BookShelf">NBK545867</ID></Citation><Citation Type="practice guideline" Abbrev="ACMG ACT, 2019"><CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, BRCA1 and BRCA2 Pathogenic Variants (Hereditary Breast and Ovarian Cancer), 2019</CitationText></Citation><Citation Type="practice guideline" Abbrev="NICE, 2023"><URL>https://www.nice.org.uk/guidance/cg164</URL><CitationText>UK NICE Clinical Guideline CG164, Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer, 2023</CitationText></Citation><Citation Type="practice guideline" Abbrev="NICE, 2025"><URL>https://www.nice.org.uk/guidance/ng101</URL><CitationText>UK NICE Guideline NG101, Early and locally advanced breast cancer: diagnosis and management, 2025</CitationText></Citation><Citation Type="practice guideline" Abbrev="UK NICE Clinical Guideline, 2025"><URL>https://www.nice.org.uk/guidance/cg81</URL><CitationText>Advanced breast cancer: diagnosis and treatment, CG81, 2025</CitationText></Citation><XRef ID="227535" DB="Orphanet"/><XRef ID="C0346153" DB="MedGen"/><XRef ID="MONDO:0016419" DB="MONDO"/><XRef Type="MIM" ID="114480" DB="OMIM"/></Trait><Trait ID="3682" Type="Disease"><Name><ElementValue Type="Alternate">Osteosarcoma, somatic</ElementValue></Name><Name><ElementValue Type="Preferred">Bone osteosarcoma</ElementValue><XRef ID="MONDO:0002629" DB="MONDO"/></Name><Symbol><ElementValue Type="Alternate">OSRC</ElementValue><XRef Type="MIM" ID="259500" DB="OMIM"/></Symbol><AttributeSet><Attribute Type="GARD id" integerValue="7284"/><XRef ID="7284" DB="Office of Rare Diseases"/></AttributeSet><Citation Type="practice guideline" Abbrev="NCCN, 2024"><URL>https://www.nccn.org/professionals/physician_gls/pdf/bone.pdf</URL><CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines速) Bone Cancer, 2024</CitationText></Citation><XRef ID="668" DB="Orphanet"/><XRef ID="C0585442" DB="MedGen"/><XRef ID="MONDO:0002629" DB="MONDO"/><XRef Type="MIM" ID="259500" DB="OMIM"/></Trait></TraitSet></ConditionList></GermlineClassification></Classifications><ClinicalAssertionList><ClinicalAssertion ID="498361" SubmissionDate="2016-03-03" ContributesToAggregateClassification="true" DateLastUpdated="2016-03-20" DateCreated="2016-03-20"><ClinVarSubmissionID localKey="c.1283C>T" localKeyIsSubmitted="1" submittedAssembly="GRCh37"/><ClinVarAccession Accession="SCV000266068" DateUpdated="2016-03-20" DateCreated="2016-03-20" Type="SCV" Version="1" SubmitterName="University of Washington Department of Laboratory Medicine, University of Washington" OrgID="506834" OrganizationCategory="laboratory"/><RecordStatus>current</RecordStatus><Classification DateLastEvaluated="2015-11-20"><ReviewStatus>criteria provided, single submitter</ReviewStatus><GermlineClassification>Pathogenic</GermlineClassification></Classification><Assertion>variation to disease</Assertion><AttributeSet><Attribute Type="AssertionMethod">Shirts et al. (Genet Med 2016)</Attribute><Citation><ID Source="PubMed">26845104</ID></Citation></AttributeSet><ObservedInList><ObservedIn><Sample><Origin>germline</Origin><Species TaxonomyId="9606">human</Species><Age Type="minimum" age_unit="years">60</Age><Age Type="maximum" age_unit="years">69</Age><AffectedStatus>unknown</AffectedStatus><NumberTested>1</NumberTested></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="VariantAlleles" integerValue="1"/></ObservedData><ObservedData><Attribute Type="SampleLocalID">789</Attribute></ObservedData><TraitSet Type="Finding"><Trait ClinicalFeaturesAffectedStatus="present" Type="Finding"><Name><ElementValue Type="Preferred">pancreatic cancer</ElementValue></Name></Trait></TraitSet></ObservedIn><ObservedIn><Sample><Origin>germline</Origin><Species TaxonomyId="9606">human</Species><Age Type="minimum" age_unit="years">60</Age><Age Type="maximum" age_unit="years">69</Age><AffectedStatus>yes</AffectedStatus><NumberTested>1</NumberTested></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="VariantAlleles" integerValue="1"/></ObservedData><ObservedData><Attribute Type="SampleLocalID">847</Attribute></ObservedData><TraitSet Type="Finding"><Trait ClinicalFeaturesAffectedStatus="present" Type="Finding"><Name><ElementValue Type="Preferred">breast cancer</ElementValue></Name></Trait></TraitSet></ObservedIn><ObservedIn><Sample><Origin>germline</Origin><Species TaxonomyId="9606">human</Species><Age Type="minimum" age_unit="years">50</Age><Age Type="maximum" age_unit="years">59</Age><AffectedStatus>yes</AffectedStatus><NumberTested>1</NumberTested></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="VariantAlleles" integerValue="1"/></ObservedData><ObservedData><Attribute Type="SampleLocalID">1400</Attribute></ObservedData><TraitSet Type="Finding"><Trait ClinicalFeaturesAffectedStatus="present" Type="Finding"><Name><ElementValue Type="Preferred">lobular breast cancer</ElementValue></Name></Trait></TraitSet></ObservedIn></ObservedInList><SimpleAllele><GeneList><Gene Symbol="CHEK2"/></GeneList><VariantType>Variation</VariantType><AttributeSet><Attribute Type="HGVS">NM_007194.3:c.1283C>T</Attribute></AttributeSet></SimpleAllele><TraitSet Type="Disease"><Trait Type="Disease"><XRef DB="MedGen" ID="C1858433" Type="CUI"/></Trait></TraitSet><SubmissionNameList><SubmissionName>GIM_BROCA</SubmissionName></SubmissionNameList></ClinicalAssertion><ClinicalAssertion ID="1193578" SubmissionDate="2017-05-23" ContributesToAggregateClassification="true" DateLastUpdated="2017-11-11" DateCreated="2017-11-11"><ClinVarSubmissionID localKey="NM_007194.3:c.1283C>T|OMIM:114480;176807;259500;609265" submittedAssembly="GRCh37"/><ClinVarAccession Accession="SCV000611259" DateUpdated="2017-11-11" DateCreated="2017-11-11" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory"/><RecordStatus>current</RecordStatus><Classification DateLastEvaluated="2017-05-18"><ReviewStatus>criteria provided, single submitter</ReviewStatus><GermlineClassification>Pathogenic</GermlineClassification></Classification><Assertion>variation to disease</Assertion><AttributeSet><Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute><Citation><ID Source="PubMed">25741868</ID></Citation></AttributeSet><ObservedInList><ObservedIn><Sample><Origin>unknown</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>unknown</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="Description">not provided</Attribute></ObservedData></ObservedIn></ObservedInList><SimpleAllele><GeneList><Gene Symbol="CHEK2"/></GeneList><VariantType>Variation</VariantType><AttributeSet><Attribute Type="HGVS">NM_007194.3:c.1283C>T</Attribute></AttributeSet></SimpleAllele><TraitSet Type="Disease"><Trait Type="Disease"><XRef DB="OMIM" ID="114480" Type="MIM"/></Trait><Trait Type="Disease"><XRef DB="OMIM" ID="176807" Type="MIM"/></Trait><Trait Type="Disease"><XRef DB="OMIM" ID="259500" Type="MIM"/></Trait><Trait Type="Disease"><XRef DB="OMIM" ID="609265" Type="MIM"/></Trait></TraitSet><SubmissionNameList><SubmissionName>SUB2717140</SubmissionName></SubmissionNameList></ClinicalAssertion><ClinicalAssertion ID="3962971" SubmissionDate="2023-03-01" ContributesToAggregateClassification="true" DateLastUpdated="2023-03-11" DateCreated="2021-11-29"><ClinVarSubmissionID localKey="b23be1a571e5e4b53f6a02be011007f284d969cd2292229675e151f9c720b1a1|not provided" submittedAssembly="GRCh37"/><ClinVarAccession Accession="SCV002019286" DateUpdated="2023-03-11" DateCreated="2021-11-29" Type="SCV" Version="2" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory"/><RecordStatus>current</RecordStatus><Classification DateLastEvaluated="2019-01-14"><ReviewStatus>criteria provided, single submitter</ReviewStatus><GermlineClassification>Pathogenic</GermlineClassification></Classification><Assertion>variation to disease</Assertion><AttributeSet><Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute><Citation><ID Source="PubMed">25741868</ID></Citation></AttributeSet><ObservedInList><ObservedIn><Sample><Origin>germline</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>unknown</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="Description">not provided</Attribute></ObservedData></ObservedIn></ObservedInList><SimpleAllele><VariantType>Variation</VariantType><AttributeSet><Attribute Type="HGVS">NM_007194.4:c.1283C>T</Attribute></AttributeSet></SimpleAllele><TraitSet Type="Disease"><Trait Type="Disease"><Name><ElementValue Type="Preferred">not provided</ElementValue></Name></Trait></TraitSet><SubmissionNameList><SubmissionName>SUB10694847</SubmissionName><SubmissionName>SUB12926214</SubmissionName></SubmissionNameList></ClinicalAssertion><ClinicalAssertion ID="3925945" SubmissionDate="2023-07-12" ContributesToAggregateClassification="true" DateLastUpdated="2023-07-16" DateCreated="2021-11-06"><ClinVarSubmissionID localKey="Chr.22_28695219_28695219_G_A|not provided"/><ClinVarAccession Accession="SCV002009509" DateUpdated="2023-07-16" DateCreated="2021-11-06" Type="SCV" Version="3" SubmitterName="Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden" OrgID="505632" OrganizationCategory="clinic" OrgAbbreviation="KGE"/><RecordStatus>current</RecordStatus><Classification DateLastEvaluated="2021-11-03"><ReviewStatus>criteria provided, single submitter</ReviewStatus><GermlineClassification>Likely pathogenic</GermlineClassification></Classification><Assertion>variation to disease</Assertion><AttributeSet><Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute><Citation><ID Source="PubMed">25741868</ID></Citation></AttributeSet><ObservedInList><ObservedIn><Sample><Origin>germline</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>not provided</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="Description">not provided</Attribute></ObservedData></ObservedIn></ObservedInList><SimpleAllele><VariantType>Variation</VariantType><Location><SequenceLocation Assembly="GRCh38" Chr="22" alternateAllele="A" referenceAllele="G" start="28695219" stop="28695219"/></Location></SimpleAllele><TraitSet Type="Disease"><Trait Type="Disease"><Name><ElementValue Type="Preferred">not provided</ElementValue></Name></Trait></TraitSet><SubmissionNameList><SubmissionName>SUB10612882</SubmissionName><SubmissionName>SUB13603663</SubmissionName><SubmissionName>SUB13676335</SubmissionName></SubmissionNameList></ClinicalAssertion><ClinicalAssertion ID="10082147" SubmissionDate="2024-08-16" ContributesToAggregateClassification="false" DateLastUpdated="2024-08-18" DateCreated="2024-08-18"><ClinVarSubmissionID localKey="27745|Orphanet:145"/><ClinVarAccession Accession="SCV005196404" DateUpdated="2024-08-18" DateCreated="2024-08-18" Type="SCV" Version="1" SubmitterName="German Consortium for Hereditary Breast and Ovarian Cancer, University Hospital Cologne" OrgID="506864" OrganizationCategory="consortium" OrgAbbreviation="GC-HBOC"/><RecordStatus>current</RecordStatus><Classification DateLastEvaluated="2024-04-09"><ReviewStatus>no assertion criteria provided</ReviewStatus><GermlineClassification>Likely pathogenic, low penetrance</GermlineClassification><Comment>According to the ACMG SVI adaptation criteria we chose this criterion: PS4 (strong pathogenic): Risikoallel; funktionelle Analysen jetzt wiedersp端chlich, Stolarova nicht damaging, 辰ltere Analysen eher damaging => kein PS3, kein PM2, PS4-str: OR 2,13; in vielen Frauen >70 ohne</Comment></Classification><Assertion>variation to disease</Assertion><ObservedInList><ObservedIn><Sample><Origin>germline</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>not provided</AffectedStatus></Sample><Method><MethodType>curation</MethodType></Method><ObservedData><Attribute Type="Description">not provided</Attribute></ObservedData></ObservedIn></ObservedInList><SimpleAllele><GeneList><Gene Symbol="CHEK2"/></GeneList><VariantType>Variation</VariantType><Location><SequenceLocation Assembly="GRCh38" Chr="22" alternateAllele="A" referenceAllele="G" start="28695219" stop="28695219"/></Location><OtherNameList><Name Type="SubmitterVariantId">27745</Name></OtherNameList></SimpleAllele><TraitSet Type="Disease"><Trait Type="Disease"><XRef DB="Orphanet" ID="145"/></Trait></TraitSet><SubmissionNameList><SubmissionName>SUB14669239</SubmissionName></SubmissionNameList></ClinicalAssertion><ClinicalAssertion ID="8838596" SubmissionDate="2024-10-02" ContributesToAggregateClassification="false" DateLastUpdated="2024-10-08" DateCreated="2024-03-16"><ClinVarSubmissionID localKey="1526122|CHEK2-related condition"/><ClinVarAccession Accession="SCV004752724" DateUpdated="2024-10-08" DateCreated="2024-03-16" Type="SCV" Version="2" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory"/><RecordStatus>current</RecordStatus><Classification DateLastEvaluated="2024-08-23"><ReviewStatus>no assertion criteria provided</ReviewStatus><GermlineClassification>Pathogenic</GermlineClassification><Comment>The CHEK2 c.1283C>T variant is predicted to result in the amino acid substitution p.Ser428Phe. This variant has previously been reported in control populations.</Comment></Classification><Assertion>variation to disease</Assertion><ObservedInList><ObservedIn><Sample><Origin>germline</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>unknown</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="Description">not provided</Attribute></ObservedData></ObservedIn></ObservedInList><SimpleAllele><GeneList><Gene Symbol="CHEK2"/></GeneList><VariantType>Variation</VariantType><OtherNameList><Name Type="SubmitterVariantId">1526122</Name></OtherNameList><AttributeSet><Attribute Type="HGVS">NM_007194.3:c.1283C>T</Attribute></AttributeSet></SimpleAllele><TraitSet Type="Disease"><Trait Type="Disease"><Name><ElementValue Type="Preferred">CHEK2-related condition</ElementValue></Name></Trait></TraitSet><SubmissionNameList><SubmissionName>SUB14299258</SubmissionName><SubmissionName>SUB14767642</SubmissionName></SubmissionNameList></ClinicalAssertion><ClinicalAssertion ID="10858246" SubmissionDate="2024-12-20" ContributesToAggregateClassification="true" DateLastUpdated="2025-01-25" DateCreated="2025-01-25"><ClinVarSubmissionID localKey="(v1:FilteredVar)[GRCh37]chr22/29091207:29091207(G:A:)NM_007194.4|OMIM:176807;259500;609265" submittedAssembly="GRCh37"/><ClinVarAccession Accession="SCV005663098" DateUpdated="2025-01-25" DateCreated="2025-01-25" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory"/><RecordStatus>current</RecordStatus><Classification DateLastEvaluated="2024-05-13"><ReviewStatus>criteria provided, single submitter</ReviewStatus><GermlineClassification>Pathogenic</GermlineClassification></Classification><Assertion>variation to disease</Assertion><AttributeSet><Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute><Citation><ID Source="PubMed">25741868</ID></Citation></AttributeSet><ObservedInList><ObservedIn><Sample><Origin>germline</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>unknown</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="Description">not provided</Attribute></ObservedData></ObservedIn></ObservedInList><SimpleAllele><VariantType>Variation</VariantType><AttributeSet><Attribute Type="HGVS">NM_007194.4:c.1283C>T</Attribute></AttributeSet></SimpleAllele><TraitSet Type="Disease" multipleConditionExplanation="Uncertain"><Trait Type="Disease"><XRef DB="OMIM" ID="176807" Type="MIM"/></Trait><Trait Type="Disease"><XRef DB="OMIM" ID="259500" Type="MIM"/></Trait><Trait Type="Disease"><XRef DB="OMIM" ID="609265" Type="MIM"/></Trait></TraitSet><SubmissionNameList><SubmissionName>SUB14944800</SubmissionName></SubmissionNameList></ClinicalAssertion><ClinicalAssertion ID="469077" SubmissionDate="2025-02-07" ContributesToAggregateClassification="true" DateLastUpdated="2025-02-25" DateCreated="2015-10-11"><ClinVarSubmissionID localKey="173753|MedGen:C0346153" submittedAssembly="GRCh37"/><ClinVarAccession Accession="SCV000253983" DateUpdated="2025-02-25" DateCreated="2015-10-11" Type="SCV" Version="14" SubmitterName="Labcorp Genetics (formerly Invitae), Labcorp" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae"/><RecordStatus>current</RecordStatus><Classification DateLastEvaluated="2025-01-31"><ReviewStatus>criteria provided, single submitter</ReviewStatus><GermlineClassification>Pathogenic, low penetrance</GermlineClassification><Citation><ID Source="PubMed">15649950</ID></Citation><Citation><ID Source="PubMed">22419737</ID></Citation><Citation><ID Source="PubMed">22419737</ID></Citation><Citation><ID Source="PubMed">15649950</ID></Citation><Citation><ID Source="PubMed">22419737</ID></Citation><Citation><ID Source="PubMed">15649950</ID></Citation><Comment>This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 428 of the CHEK2 protein (p.Ser428Phe). This variant is present in population databases (rs137853011, gnomAD 1.1%), and has an allele count higher than expected for a pathogenic variant. In a large case-control study of Ashkenazi Jewish women, this variant was found in 2.9% of individuals with breast cancer and 1.4% of individuals with no prior indication of cancer. This translates to ~2-fold increased risk (OR=2.13, 95% CI [1.26, 3.69], P=0.004) of breast cancer for c.1283C>T carriers in this population (PMID: 15649950). Outside of the Ashkenazi Jewish population this variant is very rare.</Comment></Classification><Assertion>variation to disease</Assertion><AttributeSet><Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute><Citation><ID Source="PubMed">28492532</ID></Citation></AttributeSet><ObservedInList><ObservedIn><Sample><Origin>germline</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>unknown</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="Description">not provided</Attribute></ObservedData></ObservedIn></ObservedInList><SimpleAllele><GeneList><Gene Symbol="CHEK2"/></GeneList><VariantType>Variation</VariantType><AttributeSet><Attribute Type="HGVS">NC_000022.10:g.29091207G>A</Attribute></AttributeSet></SimpleAllele><TraitSet Type="Disease"><Trait Type="Disease"><XRef DB="MedGen" ID="C0346153" Type="CUI"/></Trait></TraitSet><Citation Type="general"><ID Source="PubMed">28492532</ID></Citation><SubmissionNameList><SubmissionName>SUB11431369</SubmissionName><SubmissionName>SUB12507860</SubmissionName><SubmissionName>SUB14200279</SubmissionName><SubmissionName>SUB15075354</SubmissionName><SubmissionName>SUB8755776</SubmissionName></SubmissionNameList></ClinicalAssertion><TraitMappingList><TraitMapping ClinicalAssertionID="7894954" TraitType="Disease" MappingType="Name" MappingValue="Not provided" MappingRef="Preferred"><MedGen CUI="C3661900" Name="not provided"/></TraitMapping><TraitMapping ClinicalAssertionID="3962971" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred"><MedGen CUI="C3661900" Name="not provided"/></TraitMapping><TraitMapping ClinicalAssertionID="3442426" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003002" MappingRef="HP"><MedGen CUI="C0678222" Name="Breast carcinoma"/></TraitMapping><TraitMapping ClinicalAssertionID="8838596" TraitType="Disease" MappingType="Name" MappingValue="CHEK2-related condition" MappingRef="Preferred"><MedGen CUI="None" Name="CHEK2-related disorder"/></TraitMapping><TraitMapping ClinicalAssertionID="1790057" TraitType="Disease" MappingType="Name" MappingValue="CHEK2-Related Cancer Susceptibility" MappingRef="Preferred"><MedGen CUI="C5882668" Name="CHEK2-related cancer predisposition"/></TraitMapping><TraitMapping ClinicalAssertionID="4961845" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen"><MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome"/></TraitMapping><TraitMapping ClinicalAssertionID="1193578" TraitType="Disease" MappingType="XRef" MappingValue="114480" MappingRef="OMIM"><MedGen CUI="C0346153" Name="Familial cancer of breast"/></TraitMapping><TraitMapping ClinicalAssertionID="1193578" TraitType="Disease" MappingType="XRef" MappingValue="609265" MappingRef="OMIM"><MedGen CUI="C5882668" Name="CHEK2-related cancer predisposition"/></TraitMapping><TraitMapping ClinicalAssertionID="3442426" TraitType="Disease" MappingType="XRef" MappingValue="CN239278" MappingRef="MedGen"><MedGen CUI="C5882668" Name="CHEK2-related cancer predisposition"/></TraitMapping><TraitMapping ClinicalAssertionID="1164843" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred"><MedGen CUI="C3661900" Name="not provided"/></TraitMapping><TraitMapping ClinicalAssertionID="3745744" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred"><MedGen CUI="C3661900" Name="not provided"/></TraitMapping><TraitMapping ClinicalAssertionID="498361" TraitType="Disease" MappingType="XRef" MappingValue="C1858433" MappingRef="MedGen"><MedGen CUI="CN068920" Name="Breast and colorectal cancer, susceptibility to"/></TraitMapping><TraitMapping ClinicalAssertionID="3442426" TraitType="Finding" MappingType="XRef" MappingValue="HP:0032317" MappingRef="HP"><MedGen CUI="C0260515" Name="Family history of cancer"/></TraitMapping><TraitMapping ClinicalAssertionID="7916389" TraitType="Disease" MappingType="XRef" MappingValue="CN221562" MappingRef="MedGen"><MedGen CUI="CN221562" Name="Breast and/or ovarian cancer"/></TraitMapping><TraitMapping ClinicalAssertionID="1609791" TraitType="Disease" MappingType="Name" MappingValue="Hereditary cancer-predisposing syndrome" MappingRef="Preferred"><MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome"/></TraitMapping><TraitMapping ClinicalAssertionID="11697230" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen"><MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome"/></TraitMapping><TraitMapping ClinicalAssertionID="1365121" TraitType="Disease" MappingType="XRef" MappingValue="C0677776" MappingRef="MedGen"><MedGen CUI="C0677776" Name="Hereditary breast ovarian cancer syndrome"/></TraitMapping><TraitMapping ClinicalAssertionID="7901002" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen"><MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome"/></TraitMapping><TraitMapping ClinicalAssertionID="469077" TraitType="Disease" MappingType="XRef" MappingValue="C0346153" MappingRef="MedGen"><MedGen CUI="C0346153" Name="Familial cancer of breast"/></TraitMapping><TraitMapping ClinicalAssertionID="10858246" TraitType="Disease" MappingType="XRef" MappingValue="609265" MappingRef="OMIM"><MedGen CUI="C5882668" Name="CHEK2-related cancer predisposition"/></TraitMapping><TraitMapping ClinicalAssertionID="4894632" TraitType="Disease" MappingType="Name" MappingValue="Not provided" MappingRef="Preferred"><MedGen CUI="C3661900" Name="not provided"/></TraitMapping><TraitMapping ClinicalAssertionID="556564" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen"><MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome"/></TraitMapping><TraitMapping ClinicalAssertionID="3049691" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0007254" MappingRef="MONDO"><MedGen CUI="C0006142" Name="Malignant tumor of breast"/></TraitMapping><TraitMapping ClinicalAssertionID="10858246" TraitType="Disease" MappingType="XRef" MappingValue="259500" MappingRef="OMIM"><MedGen CUI="C0585442" Name="Bone osteosarcoma"/></TraitMapping><TraitMapping ClinicalAssertionID="751236" TraitType="Disease" MappingType="Name" MappingValue="Breast Cancer" MappingRef="Preferred"><MedGen CUI="C0006142" Name="Malignant tumor of breast"/></TraitMapping><TraitMapping ClinicalAssertionID="2861148" TraitType="Disease" MappingType="Name" MappingValue="Hereditary cancer-predisposing syndrome" MappingRef="Preferred"><MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome"/></TraitMapping><TraitMapping ClinicalAssertionID="3442426" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003002" MappingRef="HP"><MedGen CUI="C0678222" Name="Breast carcinoma"/></TraitMapping><TraitMapping ClinicalAssertionID="10082116" TraitType="Disease" MappingType="Name" MappingValue="Inherited breast cancer and ovarian cancer" MappingRef="Preferred"><MedGen CUI="None" Name="Inherited breast cancer and ovarian cancer"/></TraitMapping><TraitMapping ClinicalAssertionID="4993706" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred"><MedGen CUI="C3661900" Name="not provided"/></TraitMapping><TraitMapping ClinicalAssertionID="305742" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen"><MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome"/></TraitMapping><TraitMapping ClinicalAssertionID="4050488" TraitType="Disease" MappingType="Name" MappingValue="Breast cancer, susceptibility to" MappingRef="Preferred"><MedGen CUI="C3469522" Name="Breast cancer, susceptibility to"/></TraitMapping><TraitMapping ClinicalAssertionID="498361" TraitType="Finding" MappingType="Name" MappingValue="lobular breast cancer" MappingRef="Preferred"><MedGen CUI="C0206692" Name="Breast lobular carcinoma"/></TraitMapping><TraitMapping ClinicalAssertionID="3925945" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred"><MedGen CUI="C3661900" Name="not provided"/></TraitMapping><TraitMapping ClinicalAssertionID="5037041" TraitType="Disease" MappingType="XRef" MappingValue="114480" MappingRef="OMIM"><MedGen CUI="C0346153" Name="Familial cancer of breast"/></TraitMapping><TraitMapping ClinicalAssertionID="10858246" TraitType="Disease" MappingType="XRef" MappingValue="176807" MappingRef="OMIM"><MedGen CUI="C2931456" Name="Familial prostate cancer"/></TraitMapping><TraitMapping ClinicalAssertionID="1748765" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen"><MedGen CUI="C3661900" Name="not provided"/></TraitMapping><TraitMapping ClinicalAssertionID="2939331" TraitType="Disease" MappingType="XRef" MappingValue="114480" MappingRef="OMIM"><MedGen CUI="C0346153" Name="Familial cancer of breast"/></TraitMapping><TraitMapping ClinicalAssertionID="1637491" TraitType="Disease" MappingType="XRef" MappingValue="114480" MappingRef="OMIM"><MedGen CUI="C0346153" Name="Familial cancer of breast"/></TraitMapping><TraitMapping ClinicalAssertionID="1328898" TraitType="Disease" MappingType="XRef" MappingValue="114480" MappingRef="OMIM"><MedGen CUI="C0346153" Name="Familial cancer of breast"/></TraitMapping><TraitMapping ClinicalAssertionID="10082147" TraitType="Disease" MappingType="XRef" MappingValue="145" MappingRef="Orphanet"><MedGen CUI="C0677776" Name="Hereditary breast ovarian cancer syndrome"/></TraitMapping><TraitMapping ClinicalAssertionID="270558" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred"><MedGen CUI="C3661900" Name="not provided"/></TraitMapping><TraitMapping ClinicalAssertionID="1612031" TraitType="Disease" MappingType="Name" MappingValue="Familial cancer of breast" MappingRef="Preferred"><MedGen CUI="C0346153" Name="Familial cancer of breast"/></TraitMapping><TraitMapping ClinicalAssertionID="498361" TraitType="Finding" MappingType="Name" MappingValue="breast cancer" MappingRef="Preferred"><MedGen CUI="C0006142" Name="Malignant tumor of breast"/></TraitMapping><TraitMapping ClinicalAssertionID="7866219" TraitType="Disease" MappingType="XRef" MappingValue="114480" MappingRef="OMIM"><MedGen CUI="C0346153" Name="Familial cancer of breast"/></TraitMapping><TraitMapping ClinicalAssertionID="3255624" TraitType="Disease" MappingType="Name" MappingValue="CHEK2-related cancer risk" MappingRef="Preferred"><MedGen CUI="None" Name="CHEK2-related cancer risk"/></TraitMapping><TraitMapping ClinicalAssertionID="498361" TraitType="Finding" MappingType="Name" MappingValue="pancreatic cancer" MappingRef="Preferred"><MedGen CUI="C0346647" Name="Malignant tumor of pancreas"/></TraitMapping><TraitMapping ClinicalAssertionID="1193578" TraitType="Disease" MappingType="XRef" MappingValue="176807" MappingRef="OMIM"><MedGen CUI="C2931456" Name="Familial prostate cancer"/></TraitMapping><TraitMapping ClinicalAssertionID="1193578" TraitType="Disease" MappingType="XRef" MappingValue="259500" MappingRef="OMIM"><MedGen CUI="C0585442" Name="Bone osteosarcoma"/></TraitMapping><TraitMapping ClinicalAssertionID="3745744" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003002" MappingRef="HP"><MedGen CUI="C0678222" Name="Breast carcinoma"/></TraitMapping><TraitMapping ClinicalAssertionID="26135" TraitType="Disease" MappingType="Name" MappingValue="TUMOR PREDISPOSITION SYNDROME 4, BREAST" MappingRef="Preferred"><MedGen CUI="C5882772" Name="TUMOR PREDISPOSITION SYNDROME 4, BREAST"/></TraitMapping></TraitMappingList></ClinicalAssertionList></ClassifiedRecord></VariationArchive></ClinVarVariationRelease>'''

class ReloadClinvarAllVariantsTest(TestCase):
    databases = '__all__'

    @responses.activate
    @mock.patch('seqr.management.commands.reload_clinvar_all_variants.logger.info')
    def test_normal_command(self, mock_logger):
        responses.add(responses.GET, WEEKLY_XML_RELEASE, status=200, body=gzip.compress(WEEKLY_XML_RELEASE_DATA.encode()), stream=True)
        call_command('reload_clinvar_all_variants')
        mock_logger.assert_has_calls([
            mock.call('Updating ClinvarAllVariants tables to 2025-06-30'),
        ])
        self.assertEqual(True, False)
